Clinical Trial Update: Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is evaluating ticagrelor-based de-escalation of dual antiplatelet therapy in patients with ischemic stroke or transient ischemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Mazandaran University of Medical Sciences | Conditions: Ischemic Stroke, Transient Ischemic Attack | Phase 2, Phase 3 | Status: RECRUITING